Skip to main content

Table 2 Type and line of therapy, treatment response and CTCs results before and during the course of therapy from 33 colorectal cancer patients

From: Prognostic and predictive value of circulating tumor cell analysis in colorectal cancer patients

PatientID Therapy Line of therapy Staging outcome CTCs before therapy CTCs during therapy
1–4 weeks 5–8 weeks 9–12 weeks
5 FOLFIRI+Beva 2 PD + - - +
7 FUFOX 2 PD + + + +
8 FOLFIRI+Beva 2 NP + + + -
9 FUFIRI 2 PD + + + +
15 FOLFIRI 1 PD - + + +
36 FOLFOX-4 1 PD + - + +
39 FUFIRI 2 PD + - - -
47 FOLFIRI+Beva 1 NP + - - -
49 FOLFOX-4 1 NP + - + -
49 FOLFIRI 2 PD + + + +
65 Panitumumab 2 NP - - + -
65 Panitumumab 2 PD + + + +
70 FOLFOX-4 1 NP - - + -
73 FOLFOX-4 1 PD + - - +
74 FOLFIRI+Beva 2 PD + + + +
77 AIO+Beva 1 NP + + + -
80 FOLFIRI+Beva 1 NP - - - -
81 FUFIRI 1 PD - + + +
81 FUFOX 2 PD + + + +
87 AIO 1 NP + - - +
91 AIO +Beva 2 NP - - - -
97 FOLFIRI +Beva 1 NP + + + +
97 FOLFIRI +Beva 1 PD + + + -
99 FOLFOX-4 1 NP - - - -
109 AIO 1 PD + + + +
112 FOLFIR+Beva 1 NP - + - -
139 FOLFIR+Beva 1 NP + + - -
150 AIO +Beva 1 NP - - - -
151 FUFOX 1 NP + + - +
151 FUFOX 1 PD + + + +
171 FOLFOX-4 1 NP + - - -
184 AIO 1 NP - - - -
195 AIO 1 PD + + + +